Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 7/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 3/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.38 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18156397 | 0.90 | FFAR4 (0.41) | PPARAFFAR4FFAR1MRGPRX4SLC22A12 | |
| SCHEMBL18182154 | 0.90 | MAPT (0.36) | LMNAMAPTRAB9AL3MBTL1FFAR1 | |
| SCHEMBL18182357 | 0.90 | LMNA (0.45) | PPARAFFAR4LMNAMAPTRAB9A | |
| SCHEMBL18156379 | 0.89 | FFAR4 (0.42) | PPARAFFAR4LMNAMAPTRAB9A | |
| SCHEMBL18182279 | 0.89 | FFAR4 (0.42) | PPARAFFAR4FFAR1MRGPRX4SLC22A12 | |
| SCHEMBL18182775 | 0.89 | TAS1R3 (0.44) | PPARAFFAR4LMNAMAPTRAB9A | |
| SCHEMBL18182751 | 0.89 | FFAR4 (0.45) | PPARAFFAR4LMNAMAPTRAB9A | |
| SCHEMBL18156154 | 0.88 | PPARA (0.41) | PPARAFFAR4LMNAMAPTRAB9A | |
| SCHEMBL18182738 | 0.88 | LMNA (0.42) | LMNARAB9AFFAR1MRGPRX4CD274 | |
| SCHEMBL18156096 | 0.88 | MRGPRX4 (0.41) | MAPTRAB9AMRGPRX4CD274 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573904-B2 | Aromatic compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-21 | — | — | US | disclosed |
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-10-27 | — | — | US | disclosed |
| EP-3081559-A1 | AROMATIC COMPOUND AND APPLICATION FOR SAME | Sumitomo Chemical Company, Limited (JP) | 2016-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160311775-A1 | AROMATIC COMPOUND AND USE THEREOF | ZCCHC8, CBR3, CBX8 | PPARA 3076/4885FFAR4 2485/4885LMNA 4171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.